Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122025075 | 12202507 | 5 | F | 20160210 | 20160830 | 20160322 | 20160912 | EXP | GB-ROCHE-1727329 | ROCHE | 78.69 | YR | F | Y | 0.00000 | 20160909 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122025075 | 12202507 | 1 | PS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 125409 | 420 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 122025075 | 12202507 | 2 | SS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 125409 | 840 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 122025075 | 12202507 | 3 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 103792 | 472.5 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 122025075 | 12202507 | 4 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 103792 | 630 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 122025075 | 12202507 | 5 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | PLANNED NUMBER OF CYCLES COMPLETED | Y | 0 | 94 | MG | Q3W | ||||||
| 122025075 | 12202507 | 6 | C | TAXOTERE | DOCETAXEL | 1 | Intravenous (not otherwise specified) | CHEMOTHERAPY | 0 | 94 | MG | Q3W | |||||||
| 122025075 | 12202507 | 7 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Intravenous (not otherwise specified) | 0 | 10 | MG | |||||||||
| 122025075 | 12202507 | 8 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Intravenous (not otherwise specified) | 0 | 10 | MG | |||||||||
| 122025075 | 12202507 | 9 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | 8 | MG | BID | ||||||||
| 122025075 | 12202507 | 10 | C | Filgrastim | FILGRASTIM | 1 | Intravenous (not otherwise specified) | 0 | 480 | UG | |||||||||
| 122025075 | 12202507 | 11 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 0 | 8 | MG | TABLET | BID | |||||||
| 122025075 | 12202507 | 12 | C | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | Oral | 0 | 500 | MG | TABLET | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122025075 | 12202507 | 1 | HER-2 positive breast cancer |
| 122025075 | 12202507 | 3 | HER-2 positive breast cancer |
| 122025075 | 12202507 | 5 | HER-2 positive breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122025075 | 12202507 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122025075 | 12202507 | Decreased appetite | |
| 122025075 | 12202507 | Deep vein thrombosis | |
| 122025075 | 12202507 | Diarrhoea | |
| 122025075 | 12202507 | Dyspepsia | |
| 122025075 | 12202507 | Fatigue | |
| 122025075 | 12202507 | Nausea | |
| 122025075 | 12202507 | Peripheral swelling | |
| 122025075 | 12202507 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122025075 | 12202507 | 1 | 20160212 | 0 | ||
| 122025075 | 12202507 | 2 | 20160121 | 20160121 | 0 | |
| 122025075 | 12202507 | 3 | 20160212 | 0 | ||
| 122025075 | 12202507 | 4 | 20160121 | 20160121 | 0 | |
| 122025075 | 12202507 | 5 | 20160122 | 20160520 | 0 | |
| 122025075 | 12202507 | 6 | 20160122 | 0 | ||
| 122025075 | 12202507 | 7 | 20160122 | 20160122 | 0 | |
| 122025075 | 12202507 | 8 | 20160112 | 20160112 | 0 | |
| 122025075 | 12202507 | 9 | 20160121 | 20160123 | 0 | |
| 122025075 | 12202507 | 10 | 20160123 | 20160127 | 0 | |
| 122025075 | 12202507 | 11 | 20160211 | 20160214 | 0 | |
| 122025075 | 12202507 | 12 | 20160427 | 0 |